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Background: Venous thromboembolism (VTE) prophylaxis is underutilized for hospitalized patients. The primary
objective of this study was to assess the impact of a continuing medical education (CME) program on
thromboprophylaxis and VTE-associated mortality in a tertiary-care hospital.
Methods: This was a retrospective study of all patients admitted to a tertiary-care hospital from 01/07/2009 to 30/
06/2010 (after a CME program that aimed at improving VTE prophylaxis) and had confirmed VTE during stay. VTE
prophylaxis utilization and associated mortality were assessed in them and compared to those of a similar cohort of
patients hospitalized in the previous 12 months.
Results: There were 147 confirmed VTE cases in the study period (surgical: 26.5% and medical: 73.5%). Most (63.9%)
VTE patients received prophylaxis after the CME program compared with 36.5% in the previous 12 months (relative
risk 1.73; 95% confidence interval, 1.38-2.18; P < 0.001). More surgical (82.1%) than medical (57.4%) patients received
prophylaxis (P < 0.01). VTE-associated mortality rate was 10.9% with a significant decrease after the CME program
(relative risk, 0.52; 95% confidence interval, 0.30-0.90). This mortality was lower for those who received VTE prophylaxis
compared to those who didn’t (4.3% and 22.6%, respectively; P < 0.01). Additionally, VTE-associated deaths represented
1.1% of total hospital mortality compared to 1.9% in the 12 months before CME program (relative risk, 0.58; 95%
confidence interval, 0.32-1.04; P = 0.07).
Conclusions: A CME educational program to improve VTE prophylaxis in a tertiary-care hospital was associated with
improvement in VTE prophylaxis utilization and VTE-associated mortality. Such programs are highly recommended.
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Continuing medical educationBackground
Venous thromboembolism (VTE) is a major cause of
morbidity and mortality in hospitalized patients, account-
ing for 5-10% of in-hospital fatalities [1,2]. Although
thromboprophylaxis has been proven to be effective [3,4],
it continues to be underemployed. In the “Epidemiologic
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article, unless otherwise stated.Setting” (ENDORSE) study, a multi-national and multi-
center cross-sectional survey, only about half of hospital-
ized patients received thromboprophylaxis according to
the 2004 American College of Chest Physicians (ACCP)
guidelines [5].
The wide gap between VTE prophylaxis guidelines and
practice represents a real challenge to the medical commu-
nity. Many measures have been suggested to bridge this
gap. These measures included periodic educational sessions
to increase health care providers’ awareness of the ne-
cessity of thromboprophylaxis [6,7], incorporating throm-
boprophylaxis in medical admission order sets [8] and
electronic alerts using computer-based clinical decisiontral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Baseline characteristics of patients with




Age* (years), mean ± SD (range) 56 ± 3.98 (52.9-67.5)
Age classes, N (%)
< 40 years 1 (0.7)
40-60 years 112 (76.2)
> 60 years 31 (21.1)
Male gender, N (%) 84 (57.1)
Risk factors, N (%)






Indwelling venous device 58 (39.5)
History of infection 21 (14.3)
Inflammatory disease 77 (52.4)
Cancer 18 (12.4)
Chronic obstructive pulmonary disease 5 (3.4)
Respiratory failure 21 (14.3)
Varicose veins 16 (11.3)
History of stroke 45 (30.6)
History of heart failure 21 (14.3)
Myocardial infarction 65 (44.2)
Peripheral vascular disease 70 (47.6)
History of nephrotic syndrome 9 (6.1)
*Age was missing in 3 patients.
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these measures is variable and may be questionable.
The primary objective of the current study was to assess
the impact of a multifaceted continuing medical education
(CME) program conducted in a tertiary-care hospital on




This was a retrospective observational study that was
conducted at King Fahad General Hospital, a 900-bed
tertiary-care university-affiliated hospital in Jeddah, Saudi
Arabia. It was operated by the Saudi Ministry of Health and
admitted medical and surgical patients. We had previously
conducted a study in the same hospital to find out the rate
of VTE prophylaxis in hospitalized patients according to
the ACCP guidelines [10]. We found that for the 178 pa-
tients with confirmed VTEs that were diagnosed during
hospitalization between July 1, 2008 and June 30, 2009, only
36.5% received VTE prophylaxis (44.1% for eligible surgical
patients and 21.7% for medical patients) [10]. In this study
and after a hospital-wide CME program, we evaluated all
patients who were admitted to the hospital from July 1,
2009 to July 31, 2010 and had newly-diagnosed VTE that
occurred during hospitalization. To identify these patients,
we used the same methods of the previous study [10].
Hence, patients with ICD-9 codes related to VTE were
identified from the hospital discharge data and reviewed.
Only patients with confirmed VTE (deep vein thrombosis
[DVT] or pulmonary embolism [PE] or both) were in-
cluded. The clinical diagnosis of DVT was confirmed by ex-
tremity venous Doppler ultrasound and of PE by chest
computed tomography or echocardiography in major PE
and hemodynamic instability. During the study periods,
there was no change in the hospital operation and patient
mix. The Institutional Review Board of the hospital
approved the current study and granted waiver of consent.
The continuing medical education program
The CME program was intended to increase the hospital
staff ’s awareness of VTE burden and the value of VTE
prophylaxis and was conducted in a large conference
room on three consecutive days from June 22 to 24, 2009.
Physicians of different specialties constituted the majority
of attendees followed by registered nurses. The program
consisted of didactic lectures, which were presented in
English by physicians of different specialties and focused
on VTE epidemiology, VTE burden in different medical
and surgical specialties, VTE risk assessment, methods
of VTE prophylaxis and the evidence-based VTE prophy-
laxis guidelines. During the program, a new paper-based
VTE risk assessment tool [11] was introduced for physi-
cians to voluntarily complete for newly-admitted patients.Moreover, pocket-size booklets summarizing VTE prophy-
laxis guidelines and handouts on how to administer
low-molecular-weight heparin and provide mechanical
prophylaxis were distributed to the program attendees.
Additionally, reminder posters were thereafter continu-
ously exhibited in the various hospital wards. An attending
physician played the role of project champion advocating
VTE prophylaxis throughout the study period. The CME
program and VTE prophylaxis utilization were supported
by the hospital leadership and administration.
Data collection
We collected our data by reviewing the medical records
and hospital computerized database in a similar way to
our previous study [10]. The following information was
noted for each patient with confirmed VTE: age, sex, ad-
mission category (medical versus surgical) and VTE risk
factors (Table 1). VTE risk was categorized according to
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obtained statistics on all deaths that occurred in the hos-
pital during the study period and on in-hospital deaths
due to circulatory and respiratory collapse, which could be
caused by PE. The primary outcomes of this study were
VTE prophylaxis utilization (mechanical and/or pharma-
cological) as per the ACCP recommendations [12] before
the diagnosis of VTE and VTE-associated mortality in
the hospital.
Statistical analysis
Statistical analysis was performed using the Statistical
Package for Social Sciences (SPSS for Windows, version
17). Descriptive statistics were reported as mean with stand-
ard deviation for continuous variables and as frequency
with percentage for categorical variables. Differences be-
tween groups were tested using the Chi-square test. When-
ever any of the expected values were less than 5, Fisher’s
exact test was used instead. Comparison between previous
study [10] results and current study was also performed.
The risk of VTE prophylaxis and of VTE-associated in-
hospital mortality after the CME program was compared to
that before the program and was presented as relative risk
with 95% confidence interval. All statistical tests used were
two-tailed at a 5% level of significance.
Results
Between July 1, 2009 and June 30, 2010, 147 cases were
confirmed to have VTE during their hospitalization. Table 1
shows their baseline characteristics. Thirty nine (26.5%)
VTE patients were surgical while 108 VTE events (73.5%)
were associated with medical admissions. Most patients
were > 40 years old and males (57.1%). DVT was diagnosed
in 131 (89%) patients and 16 (11%) had DVT that pro-
gressed to PE.
VTE risk categorization
Table 2 shows the VTE risk stratification of the cohort ac-
cording to the 2008 ACCP guidelines [12]. Most (94.8%)Table 2 The relationship between venous thromboembolism pr
All patient
N = 147
VTE risk*, N (%)
Very high risk 37 (25.2)
High risk 66 (44.9)
Moderate risk 44 (29.9)
VTE prophylaxis provided, N (%) 94 (63.9)
Mortality, N (%) 16 (10.9)
Mortality in patients with VTE prophylaxis, N (%) 4 (4.3)
Mortality in patients without VTE prophylaxis, N (%) 12 (22.6)
VTE, venous thromboembolism.
*VTE risk assessment performed according to Caprini Risk Assessment Model.surgical patients were classified as very high risk, 1 (2.6%)
as high risk, and 1 (2.6%) as moderate risk. For medical
patients, 65 (60.2%) patients were high risk and 43 (39.8%)
were moderate risk.
Venous thromboembolism prophylaxis practices
Based upon the ACCP VTE prophylaxis guidelines, all
of the 147 patients in the cohort were eligible to receive
VTE prophylaxis. After the CME program, we found that
63.9% of the 147 patients who developed VTE during
hospitalization received VTE prophylaxis. This represents
a statistically significant improvement (relative risk 1.73;
95% confidence interval, 1.38-2.18; P < 0.0001) compared
to the VTE prophylaxis rate (36.5%) in our previous study
[10] (Figure 1).
The improvement in VTE prophylaxis after the CME
program was observed in both surgical and medical pa-
tients (Figure 1). However, surgical patients continued to
have higher VTE prophylaxis rates than medical patients
(82.1% and 57.4%, respectively) (Table 2). VTE prophy-
laxis was most common in very high risk surgical pa-
tients (86.5%). Almost half (49.2%) of high risk medical
patients and one third (32.6%) of moderate risk medical
patients did not receive prophylaxis. We also found that
more patients with DVT alone received VTE prophylaxis
compared to those patients who had DVT progressing
to PE (69.5% versus 26.3%; P < 0.001).
Mortality
In the current study, 16 (10.9%) patients who developed
VTE during hospitalization died compared to 37 (20.8%)
patients in the previous study (Figure 2). Hence, there
was a significant decrease in VTE-associated mortality after
the CME program (relative risk, 0.52; 95% confidence inter-
val, 0.30-0.90; P = 0.02). The mortality rate in medical pa-
tients (13%) was not significantly different compared to
that of surgical patients (5%) as shown in Table 2 (P > 0.05).
The mortality rate in medical patients was significantly
lower in the current study compared to the previous studyophylaxis and the mortality of medical and surgical patients
s Medical patients Surgical patients P value
N = 108 N = 39
0 (0) 37 (95.9) < 0.01
65 (60.2) 1 (2.6) < 0.01
43 (39.8) 1 (2.6) < 0.01
62 (57.4) 32 (82.1) < 0.01
14 (13) 2 (5.1) > 0.05
3 (4.8) 1 (3.1) > 0.05













All patients Medical patients Surgical patients
P < 0.001 P < 0.001 P < 0.001
Figure 1 Practice of venous thromboembolism prophylaxis before hospitalized patients developed deep vein thrombosis or pulmonary
embolism. This practice is described before (previous study, N = 168 patients) and after (current study, N = 147 patients) continuing medical
education program.
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surgical patients was not statistically significant (Figure 2).
In the current study, the mortality rate in the VTE pa-
tients who received prophylaxis was 4.3%, which is sig-
nificantly lower than the mortality of those who did not
receive it (22.6%; P < 0.01). The mortality difference as-
sociated with VTE prophylaxis was significant in medical
patients (P < 0.01) but not in surgical patients (P > 0.05).
All deaths occurred in very high/ high VTE risk groups.
Moreover, the mortality of patients with DVT progres-
sing to PE (16%) patients was significantly higher than
that of DVT patients (0%; P < 0.001).
During the current study period, 1464 patients died in
the hospital. The VTE-associated hospital mortality (N =
16) accounted for 1.1% of the total in hospital mortality.
This is in contrast to 37 VTE-associated deaths (1.9% of
1968 hospital deaths) in the previous study before the
CME program. Hence, the relative risk of VTE-associated
death after the CME program was 0.58 (95% confidence
interval, 0.32-1.04; P = 0.07). Nevertheless, there was noFigure 2 Venous thromboembolism-associated mortality before (prev
education program.difference in the proportion of hospital deaths due to cir-
culatory and respiratory collapse before (N = 500, 25.4%)
and after (N = 389, 26.6%) the CME program (P = 0.46).
Discussion
The main findings of this study were the following: 1- ap-
propriate VTE prophylaxis rate for patients who devel-
oped VTE during hospitalization increased significantly
from 36.5% to 63.9% after a hospital-wide CME program;
2- VTE prophylaxis utilization improved in both surgical
and medical patients; 3- VTE-associated mortality was
lower in patients receiving VTE prophylaxis and this mor-
tality risk decreased after the CME program and 4- the
proportion of hospital deaths associated with VTE tended
to decrease after the CME program.
VTE frequently complicates acute illnesses that require
hospitalization. However, VTE prophylaxis for hospitalized
patients remains underutilized. This was observed in mul-
tiple studies [5,13-15]. In a prospective study of 5,451 con-
secutive patients with ultrasonographically confirmed DVT,ious study) and after (current study) a continuing medical
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30 days before DVT diagnosis [15]. A cross-sectional sur-
vey that assessed the adherence to the 2004 ACCP VTE
prophylaxis guidelines across 32 countries showed consid-
erable variation among countries, with adherence to guide-
lines ranging from 0.2% to 92% (mean = 59%) for surgical
patients and 3% to 70% (mean = 40%) for medical patients
[5]. In our previous study in the same hospital, we found
that VTE prophylaxis was frequently missed in patients
who eventually developed VTE [10]. With the global recog-
nition of the gap between VTE prophylaxis guidelines and
real practice, different methods were suggested to improve
VTE prophylaxis utilization with variable effectiveness. In a
before-after study in a community hospital, the administra-
tion of order sets that were used voluntarily by internists
was associated with an increase in the percentage of pa-
tients who were ordered prophylaxis (44.0% versus 20.6%
for patients admitted with free text orders; P < 0.0001) [8].
Additionally, the hospital-wide DVT prophylaxis for med-
ical inpatients increased from 12.8% to 25.8% of patient-
days (P < 0.0001) [8]. Kucher et al. randomized 1,255 pa-
tients to an intervention group, in which the responsible
physician received a computer alert of the patient’s VTE
risk, and 1,251 patients to a control group, in which no
alert was issued, and found that more patients in the inter-
vention group received mechanical prophylaxis (10.0% ver-
sus 1.5%; P < 0.001) and pharmacologic prophylaxis (23.6%
versus 13.0%; P < 0.001) [9]. The computer alert reduced
VTE risk at 90 days by 41% (hazard ratio, 0.59; 95% confi-
dence interval, 0.43-0.81; P = 0.001) [9]. The effect of CME
programs on VTE prophylaxis has also been evaluated. An-
derson et al. conducted a cluster randomized trial that eval-
uated the effects of CME with or without quality assurance
on VTE prophylaxis in 3,158 high-risk medical patients and
found significant increases in the proportion of patients re-
ceiving prophylaxis in all hospitals, including the control
hospitals, over the study period (from 29% in 1986 to 52%
in 1989; P < 0.001) [6]. The increase was greater in hospitals
that had CME with or without quality assurance than the
control hospitals (+28% versus +11%; P < 0.001) [6]. A
systematic review of randomized controlled trials found
that continuing education meetings with or without other
interventions had only small effect on the clinical practice
of healthcare professionals or healthcare outcomes [16].
Additionally, the effect is probably temporary. In our study,
we have found that VTE prophylaxis in patients who de-
veloped VTE during hospitalization was significantly
higher in the one year after a hospital-wide CME program
with the increase observed in both surgical (from 44.1% to
82.1%) and medical (from 21.7% to 57.4%) patients.
Multifaceted strategies have been shown to be more
effective than any single approach in improving VTE
prophylaxis in hospitals. Scaglione et al. found that the
implementation of a multi-strategy approach made up ofeducational presentations, pocket guidelines, the imple-
mentation of a working group to identify barriers to
change and the introduction of risk-reminder cards in an
Italian teaching hospital increased the appropriate use of
VTE prophylaxis in surgical patients from 64% to 97%
[17]. Cohn et al. demonstrated that the implementation
of a multifaceted VTE prophylaxis quality improvement
program that combined regular education, dissemin-
ation of a decision support tool and regular audit-and-
feedback to resident physicians in a US hospital resulted
in an increase in appropriate VTE prophylaxis from 43%
to 68% after 12 months and to 85% after 18 months
[18]. At an Australian hospital, Gallagher et al. evaluated a
multifaceted approach and observed an increase in the
VTE risk assessment in the ward setting (7.7% to 100%;
P < 0.001), an increase in the proportion of patients receiv-
ing anticoagulant prophylaxis (48% to 74%; P = 0.01) and
a reduction in the annual VTE rate (relative risk, 0.68;
95% confidence interval, 0.47-0.99; P = 0.04) [19]. In a
study conducted in Saudi Arabia, a quality improvement
project over 14 months consisting of education of physi-
cians, development of a VTE prophylaxis protocol, weekly
monitoring of compliance, recommending VTE prophy-
laxis during the multidisciplinary rounds and feedback
whenever a deviation from the protocol occurred, was asso-
ciated with improvement in VTE prophylaxis utilization
from 63% in the initial project stage to 100% at the final
stage (overall rate = 91%) [20]. A systematic review of stud-
ies performed between 1996 and 2003 that focused on
strategies to improve VTE prophylaxis practices observed
that a passive dissemination of guidelines was associated
with poor adherence to both the guidelines and the
provision of adequate prophylaxis, and multiple strategies
were more effective than any single strategy [7]. Our CME
program included didactic lectures, distribution of VTE
prophylaxis guidelines, handouts on how to use low-
molecular-weight heparin and to provide mechanical
prophylaxis and reminder posters. It was also associated
with hospital leadership support, voluntary VTE risk assess-
ment and the presence of a champion that advocated VTE
prophylaxis. This multifaceted approach was probably be-
hind the program success.
VTE prophylaxis has been shown in multiple studies
to reduce DVT and PE [3,4,21]. However, studies on the
relationship between VTE prophylaxis and mortality have
shown mixed results. A metaanalysis based on old studies
in general surgery patients found that low-dose unfractio-
nated heparin compared with no thromboprophylaxis or
placebo was associated with decrease in all-cause mortality
from 4.2 to 3.2% [22]. Missemiti et al. found that low-
molecular-weight heparin versus placebo or no treatment
was associated with a trend toward lower mortality (rela-
tive risk, 0.54; 95% confidence interval, 0.27-1.10) [4]. A re-
cent metaanalysis of studies in nonsurgical patients found
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ratio, 0.94; 95% confidence interval, 0.84-1.04) [21]. In
the current study, patients who received prophylaxis
had lower VTE-associated death than those who did
not receive prophylaxis (4.3% and 22.6%, respectively).
This observation is interesting and suggests that VTE
prophylaxis may have led to lower mortality in patients
who eventually developed VTE. However, VTE prophy-
laxis may reflect better care in general with it being only
one component among other interventions. Additionally,
VTE-associated mortality accounted for 1.1% of the total
hospital mortality (June 2009-July 2010) compared to 1.9%
in the previous 12 months [10]. This decrease approached
statistical significance (P = 0.07) and might be related to
the CME program.
Our study has some limitations. It is a retrospective
study performed at a single center. We evaluated VTE
prophylaxis utilization only in patients who developed
VTE. However, we believe that the observed improve-
ment in VTE prophylaxis in these patients probably re-
flects a practice improvement in the other patients after
the CME program. The unavailability of the total number
of patients admitted to the hospital resulted in the inability
to provide incidence statistics. We assumed that at least a
proportion of the deaths after sudden circulatory and re-
spiratory collapse were due to undiagnosed fatal PE. This is
because post-mortem autopsy is very seldom performed in
Saudi Arabia for cultural reasons. Additionally, we evalu-
ated the effect of the educational program in one-year
period. There may have been variation in VTE prophylaxis
utilization during that year and we do not know if the
improvement was sustained in the subsequent years.
We acknowledge that the sustainability of any quality
improvement project should be considered at the initial
design process [23], which requires leadership engage-
ment, staff involvement and continuing training to sus-
tain the change processes. Moreover, we did not assess
bleeding events after hospitalization, which could have
increased after VTE prophylaxis.
Conclusions
In conclusion, a hospital-wide multifaceted CME program
that aimed at improving healthcare providers’ VTE aware-
ness and prophylaxis practices was associated with signifi-
cant improvement in VTE prophylaxis practices, reflected
by increased VTE prophylaxis utilization in patients who
developed VTE during hospitalization. This was also asso-
ciated with decrease in the mortality of these patients.
Such a multifaceted program is recommended for health-
care professionals working in acute care hospitals.
Abbreviations
ACCP: American College of Chest Physicians; CME: Continuing medical
education; DVT: Deep vein thrombosis; PE: Pulmonary embolism; VTE: Venous
thromboembolism.Competing interests
The authors received honoraria from Sanofi-Aventis, KSA for presenting in
continuing medical education programs.
Authors’ contributions
FH participated in conception and design, participated in interpretation of
data, critically revised the manuscript for important intellectual content and
approved the final version to be published. HD participated in analysis and
interpretation of data, helped to draft the manuscript, critically revised the
manuscript for important intellectual content and approved the final version
to be published. EA participated in conception and design, helped in
interpretation of data, critically revised the manuscript for important
intellectual content and approved the final version to be published. All
authors read and approved the final manuscript.
Acknowledgments
Statistical analysis was performed by Amygate Healthcare, Cairo, Egypt. The
authors thank Dr. Ahmed Omar, Manager at Sanofi, Saudi Arabia for his support.
The study was conducted at King Fahad General Hospital, Jeddah-Saudi Arabia.
Funding
The study was supported by an unrestricted grant from Sanofi-Aventis, Jeddah,
Saudi Arabia. The study sponsors had no involvement in the collection, analysis
and interpretation of data; in the writing of the manuscript; and in the decision
to submit the manuscript for publication.
Author details
1Department of Intensive Care, King Abdul-Aziz Medical City; College of
Medicine, King Saud Bin Abdul-Aziz University for Health Sciences, National
Guard Health Affairs, Jeddah, Saudi Arabia. 2Saudi Association for Venous
Thromboembolism (SAVTE), Jeddah, Saudi Arabia. 3Department of Intensive
Care, King Abdulaziz Medical City and King Saud Bin Abdulaziz University for
Health Sciences, College of Medicine, Riyadh, Saudi Arabia. 4Department of
Surgery, Medical College, University of Um Al-Qura, Mekkah, Saudi Arabia.
Received: 21 November 2013 Accepted: 20 February 2014
Published: 28 April 2014
References
1. Alikhan R, Peters F, Wilmott R, Cohen AT: Fatal pulmonary embolism in
hospitalised patients: a necropsy review. J Clin Pathol 2004,
57(12):1254–1257.
2. Sandler DA, Martin JF: Autopsy proven pulmonary embolism in hospital
patients: are we detecting enough deep vein thrombosis? J R Soc Med
1989, 82(4):203–205.
3. Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS: Meta-analysis of
venous thromboembolism prophylaxis in medically Ill patients. Clin Ther
2007, 29(11):2395–2405.
4. Mismetti P, Laporte S, Darmon JY, Buchmuller A, Decousus H: Meta-analysis
of low molecular weight heparin in the prevention of venous
thromboembolism in general surgery. Br J Surg 2001, 88(7):913–930.
5. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B,
Huang W, Zayaruzny M, Emery L, Anderson FA Jr: Venous thromboembolism
risk and prophylaxis in the acute hospital care setting (ENDORSE study): a
multinational cross-sectional study. Lancet 2008, 371(9610):387–394.
6. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A,
Patwardhan NA: Changing clinical practice. Prospective study of the
impact of continuing medical education and quality assurance programs
on use of prophylaxis for venous thromboembolism. Arch Intern Med
1994, 154(6):669–677.
7. Tooher R, Middleton P, Pham C, Fitridge R, Rowe S, Babidge W, Maddern G:
A systematic review of strategies to improve prophylaxis for venous
thromboembolism in hospitals. Ann Surg 2005, 241(3):397–415.
8. O'Connor C, Adhikari NK, DeCaire K, Friedrich JO: Medical admission order
sets to improve deep vein thrombosis prophylaxis rates and other
outcomes. J Hosp Med 2009, 4(2):81–89.
9. Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B,
Goldhaber SZ: Electronic alerts to prevent venous thromboembolism
among hospitalized patients. N Engl J Med 2005, 352(10):969–977.
Al-Hameed et al. Thrombosis Journal 2014, 12:9 Page 7 of 7
http://www.thrombosisjournal.com/content/12/1/910. Essam AE, Sharif G, Al-Hameed F: Venous thromboembolism-related
mortality and morbidity in King Fahd General Hospital, Jeddah, Kingdom
of Saudi Arabia. Ann Thorac Med 2011, 6(4):193–198.
11. Caprini JA: Thrombosis risk assessment as a guide to quality patient care.
Dis Mon 2005, 51(2–3):70–78.
12. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR,
Colwell CW: Prevention of venous thromboembolism: American college
of chest physicians evidence-based clinical practice guidelines
(8th Edition). Chest 2008, 133(6 Suppl):381S–453S.
13. Ageno W, Squizzato A, Ambrosini F, Dentali F, Marchesi C, Mera V, Steidl L,
Venco A: Thrombosis prophylaxis in medical patients: a retrospective
review of clinical practice patterns. Haematologica 2002, 87(7):746–750.
discussion 250.
14. Keane MG, Ingenito EP, Goldhaber SZ: Utilization of venous
thromboembolism prophylaxis in the medical intensive care unit. Chest
1994, 106(1):13–14.
15. Goldhaber SZ, Tapson VF: A prospective registry of 5,451 patients with
ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004,
93(2):259–262.
16. Forsetlund L, Bjorndal A, Rashidian A, Jamtvedt G, O'Brien MA, Wolf F, Davis D,
Odgaard-Jensen J, Oxman AD: Continuing education meetings and workshops:
effects on professional practice and health care outcomes. Cochrane Database
Syst Rev 2009, 2, CD003030.
17. Scaglione L, Piobbici M, Pagano E, Ballini L, Tamponi G, Ciccone G:
Implementing guidelines for venous thromboembolism prophylaxis in a
large Italian teaching hospital: lights and shadows. Haematologica 2005,
90(5):678–684.
18. Cohn SL, Adekile A, Mahabir V: Improved use of thromboprophylaxis for
deep vein thrombosis following an educational intervention. J Hosp Med
2006, 1(6):331–338.
19. Gallagher M, Oliver K, Hurwitz M: Improving the use of venous
thromboembolism prophylaxis in an Australian teaching hospital. Qual
Saf Health Care 2009, 18(5):408–412.
20. Al-Tawfiq JA, Saadeh BM: Improving adherence to venous
thromoembolism prophylaxis using multiple interventions. Ann Thorac
Med 2011, 6(2):82–84.
21. Lederle FA, Zylla D, MacDonald R, Wilt TJ: Venous thromboembolism
prophylaxis in hospitalized medical patients and those with stroke: a
background review for an American college of physicians clinical
practice guideline. Ann Intern Med 2011, 155(9):602–615.
22. Collins R, Scrimgeour A, Yusuf S, Peto R: Reduction in fatal pulmonary
embolism and venous thrombosis by perioperative administration of
subcutaneous heparin. Overview of results of randomized trials in
general, orthopedic, and urologic surgery. N Engl J Med 1988, 318
(18):1162–1173.
23. Curtis JR, Cook DJ, Wall RJ, Angus DC, Bion J, Kacmarek R, Kane-Gill SL,
Kirchhoff KT, Levy M, Mitchell PH, Moreno R, Pronovost P, Puntillo K: Intensive
care unit quality improvement: a "how-to" guide for the interdisciplinary
team. Crit Care Med 2006, 34(1):211–218.
doi:10.1186/1477-9560-12-9
Cite this article as: Al-Hameed et al.: The effect of a continuing medical
education program on Venous thromboembolism prophylaxis utilization and
mortality in a tertiary-care hospital. Thrombosis Journal 2014 12:9.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
